Profil
Henry Flanner worked as a Senior Director-Pharmaceutical Research at Middlebrook Pharmaceuticals, Inc. from 2003 to 2007.
He also worked as a Director-Drug Delivery Sciences at Shire Laboratories, Inc. and as a Vice President-Technical Operations at GlycoMimetics, Inc. Mr. Flanner received a graduate degree from The Johns Hopkins University and an undergraduate degree from the University of South Carolina.
Tidigare kända positioner av Henry Flanner
| Företag | Position | Slut |
|---|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Företagsledare/Principal | 2007-10-01 |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Företagsledare/Principal | - |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Teknisk/Vetenskaplig/F&U Direktör | - |
Henry Flanners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Commercial Services |
















